Cardiac actions of thyroid hormone metabolites

Grazia Rutigliano1, Riccardo Zucchi2

  • 1Scuola Superiore Sant'Anna, Piazza Martiri della Libertà 33, 56127 Pisa, Italy; National Research Council (CNR), Institute of Clinical Physiology (IFC), Via Giuseppe Moruzzi 1, 56124 Pisa, Italy.

Insights

Thyroid hormones (THs) and their metabolites regulate heart function through genomic and non-genomic pathways. This review details their diverse cardiac effects, including iodothyronines

Area of Science:

  • Endocrinology
  • Cardiovascular Physiology
  • Molecular Biology

Background:

  • Thyroid hormones (THs) are crucial regulators of cardiac function, primarily through genomic mechanisms.
  • Emerging research highlights non-genomic actions of THs and their metabolites (THMs) in cardiac (patho)physiology.
  • Understanding these diverse actions is vital for comprehending cardiac regulation.

Purpose of the Study:

  • To review the classical and non-classical cardiac effects of various thyroid hormone derivatives.
  • To elucidate the roles of iodothyronines, thyronamines, and iodothyroacetic acids in cardiac function.
  • To synthesize current knowledge on THs' impact on cardiac performance.

Main Methods:

  • Literature review of studies investigating thyroid hormone actions on the heart.
  • Analysis of data concerning genomic and non-genomic effects.
  • Categorization of effects based on specific thyroid hormone derivatives.

Main Results:

  • Iodothyronines (T4, T3, T2) enhance cardiac systolic and diastolic function and heart rate.
  • Thyronamines (T0AM, T1AM) exhibit negative inotropic and chronotropic effects, potentially acting as a brake on THs.
  • Thyronamines demonstrate cardioprotective effects at physiological concentrations; cardiac roles of iodothyroacetic acids require further investigation.

Conclusions:

  • Thyroid hormone derivatives exert diverse effects on cardiac function via multiple mechanisms.
  • Thyronamines may play a regulatory role in cardiac function and offer cardioprotection.
  • Further research is needed to fully elucidate the cardiac impact of iodothyroacetic acids.

Related Concept Videos

Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
6.2K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
8.5K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.8K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.7K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.8K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.2K